Please login to the form below

Not currently logged in
Email:
Password:

Dirk Poschenrieder joins Havas Life Dusseldorf

Moves to the agency from Territory to be its new managing director

Dirk Poshenrieder

Havas Life Dusseldorf has appointed Dirk Poschenrieder as its new managing director, a role that will see him continue the firm’s efforts on defining its business strategy and operations.

Prior to his new role, Poschenrieder spent the past three years leading the healthcare business unit at communications firm Territory.

He said: “I couldn’t be more excited to join Havas Life, one of the largest fully integrated, global health communication groups.

“Havas Life delivers first-class health communication which is both creative and effective and together with a fantastic team we are going to shape the future of health.

“It’s a pleasure and honour for me to be part of the Havas family.”

With more than 20 years of experience in health marketing Poschenrieder has worked for companies including Janssen (J&J) as its digital marketing manager and at Razorfish Health as digital strategy director.

Alfonoso Formariz, regional director Europe, Havas Health & You, said: “Dirk brings with him great experience in managing and developing business and a depth of expertise across strategy and digital in healthcare, which will help us continue moving to the next level.

“We have an outstanding management team in Dusseldorf, and I’m excited for the future.”

12th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics